Refine
Has Fulltext
- yes (11)
Is part of the Bibliography
- yes (11)
Document Type
- Journal article (11)
Language
- English (11)
Keywords
- Germany (2)
- ischemic stroke (2)
- stroke (2)
- Barthel-Index (1)
- Calibration (1)
- Clinical prediction rule (1)
- European countries (1)
- False positive reactions (1)
- Health care service research (1)
- Infection control (1)
- Metastatic breast cancer (1)
- Methicillin-resistant staphylococcus aureus (1)
- Patient-centered registry (1)
- Patient’s needs (1)
- Predictive value of tests (1)
- SCORE (1)
- acute ischemic stroke (1)
- atherosclerosis (1)
- biomarker (1)
- biomarkers (1)
- blood (1)
- blood coagulability (1)
- bullous pemphigoid (1)
- cardiovascular disease (1)
- cerebrovascular diseases (1)
- chronic cerebrovascular disease (1)
- clinical practice (1)
- comorbid diseases (1)
- demography (1)
- dependency (1)
- drug therapies (1)
- factor XI (1)
- factor XII (1)
- fatal cardiovascular disease (1)
- follow up (1)
- hospital medical complications (1)
- increased risk (1)
- kidney function (1)
- life style (1)
- m-Health (1)
- mice impact (1)
- myocardial infarction (1)
- platelets (1)
- polymorphisms inflammation (1)
- predictors (1)
- primary-care physicians (1)
- prognosis (1)
- quality indicators (1)
- quality of health care (1)
- quality-of-care (1)
- rankin scale (1)
- reliability (1)
- risk-factors (1)
- secondary prevention (1)
- sex addiction (1)
- smoking-cessation (1)
- stroke register (1)
- stroke unit care (1)
- task force (1)
- term mortality (1)
- trial (1)
- von Willebrand factor (1)
Institute
- Institut für Klinische Epidemiologie und Biometrie (9)
- Medizinische Klinik und Poliklinik I (4)
- Neurologische Klinik und Poliklinik (3)
- Abteilung für Molekulare Innere Medizin (in der Medizinischen Klinik und Poliklinik II) (1)
- Deutsches Zentrum für Herzinsuffizienz (DZHI) (1)
- Frauenklinik und Poliklinik (1)
- Institut für Hygiene und Mikrobiologie (1)
- Institut für Psychotherapie und Medizinische Psychologie (1)
- Klinik und Poliklinik für Dermatologie, Venerologie und Allergologie (1)
- Klinik und Poliklinik für Mund-, Kiefer- und Plastische Gesichtschirurgie (1)
Background: Animal models have implicated an integral role for coagulation factors XI (FXI) and XII (FXII) in thrombus formation and propagation of ischemic stroke (IS). However, it is unknown if these molecules contribute to IS pathophysiology in humans, and might be of use as biomarkers for IS risk and severity. This study aimed to identify predictors of altered FXI and FXII levels and to determine whether there are differences in the levels of these coagulation factors between acute cerebrovascular events and chronic cerebrovascular disease (CCD). Methods: In this case-control study, 116 patients with acute ischemic stroke (AIS) or transitory ischemic attack (TIA), 117 patients with CCD, and 104 healthy volunteers (HVs) were enrolled between 2010 and 2013 at our University hospital. Blood sampling was undertaken once in the CCD and HV groups and on days 0, 1, and 3 after stroke onset in patients with AIS or TIA. Correlations between serum FXI and FXII levels and demographic and clinical parameters were tested by linear regression and analysis of variance. Results: The mean age of AIS/TIA patients was 70 ± 12. Baseline clinical severity measured with NIHSS and Barthel Index was 4.8 ± 6.0 and 74 ± 30, respectively. More than half of the patients had an AIS (58%). FXI levels were significantly correlated with different leukocyte subsets (p < 0.05). In contrast, FXII serum levels showed no significant correlation (p > 0.1). Neither FXI nor FXII levels correlated with CRP (p > 0.2). FXII levels were significantly higher in patients with CCD compared with those with AIS/TIA (mean ± SD 106 ± 26% vs. 97 ± 24%; univariate analysis: p < 0.05); these differences did not reach significance in multivariate analysis adjusted for sex and age. FXI levels did not differ significantly between study groups. Sex and age were significantly associated with FXI and/or FXII levels in patients with AIS/TIA (p < 0.05). In contrast, no statistical significant influence was found for treatment modality (thrombolysis or not), pre-treatment with platelet inhibitors, and severity of stroke. Conclusions: In this study, there was no differential regulation of FXI and FXII levels between disease subtypes but biomarker levels were associated with patient and clinical characteristics. FXI and FXII levels might be no valid biomarker for predicting stroke risk.